LUPIN SOMERSET has expanded a previous recall to include approximately 24,180 additional bottles of Fluocinolone Acetonide Topical Solution, USP, 0.01% (60 mL). This prescription medication is being recalled because testing found elevated levels of impurities that were chemically identified as oxidative degradation products of the active ingredient. The product was distributed nationwide across the United States and Puerto Rico.
The presence of these degradation products means the medication may not meet quality standards for purity and effectiveness, potentially altering the expected therapeutic results for patients treating skin conditions.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.